Andere talen Adimmune Corporation

Aandelen

4142

TW0004142005

slotkoers Taiwan S.E. Andere beurzen 00:00:00 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28,1 ^TWD	-0,53%		-1,58%	-15,23%

15/05	Adimmune Corporation rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
28/03	Adimmune Corporation rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
An unknown buyer acquire 2.14% stake in Adimmune Corporation from BioEngine Technology Development Inc. for NTD300 million.	05/02
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Adimmune Corporation Announces Change in Representative of its Institutional Director	01/11
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	30-03-23
Clover Bio Signs Exclusive Deal to Distribute Influenza Vaccine in China; Shares Climb 3%	20-02-23
Clover Biopharmaceuticals, Ltd. Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China	20-02-23
Tranche Update on Adimmune Corporation's Equity Buyback Plan announced on November 11, 2022.	21-11-22
Adimmune Corporation's Equity Buyback announced on November 11, 2022 has closed with the repurchase of 5,000,000 shares, representing 1.17% for TWD 182.07 million.	21-11-22
Adimmune Turns Profitable in January-September	14-11-22
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Adimmune Corporation announces an Equity Buyback for 5,000,000 shares.	11-11-22
Adimmune Corporation authorizes a Buyback Plan.	11-11-22
Adimmune : The Company is invited to the online institutional investor conference hosted by Cathay Securities Corporation	16-08-22
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15-08-22
Adimmune : announces financail statements of 2022 second quarter.	12-08-22
Adimmune : To announce the completion status of execution of the stock repurchase	09-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Adimmune Corporation

Aandelen

4142

TW0004142005

Andere talen

Filters